TY - JOUR
T1 - Frequency of Adverse Systemic Reactions after Fluorescein Angiography
T2 - Results of a Prospective Study
AU - Kwiterovich, Kris A.
AU - Maguire, Maureen G.
AU - Murphy, Robert P.
AU - Schachat, Andrew P.
AU - Bressler, Neil M.
AU - Bressler, Susan B.
AU - Fine, Stuart L.
PY - 1991
Y1 - 1991
N2 - Intravenous fluorescein angiography is a commonly performed and extraordinarily valuable diagnostic procedure. The frequency of adverse reactions after angiography has varied considerably in previous reports. In a prospective study of 2789 angiographic procedures in 2025 patients, the authors found that the percentage of adverse reactions depended strongly on the patient's angiographic history. Overall, adverse reactions followed 4.8% of the angiographic procedures. These reactions included nausea (2.9%), vomiting (1.2%), flushing/itching/hives (0.5%), and other reactions (dyspnea, syncope, excessive sneezing) (0.2%). No cases of anaphylaxis, myocardial infarction, pulmonary edema, or seizures occurred. The percentage of reactions was 1.8% for patients who had had previous angiography without ever having had an adverse reaction. In contrast, the percentage of reactions was 48.6% for patients who had had an adverse reaction to angiography previously.
AB - Intravenous fluorescein angiography is a commonly performed and extraordinarily valuable diagnostic procedure. The frequency of adverse reactions after angiography has varied considerably in previous reports. In a prospective study of 2789 angiographic procedures in 2025 patients, the authors found that the percentage of adverse reactions depended strongly on the patient's angiographic history. Overall, adverse reactions followed 4.8% of the angiographic procedures. These reactions included nausea (2.9%), vomiting (1.2%), flushing/itching/hives (0.5%), and other reactions (dyspnea, syncope, excessive sneezing) (0.2%). No cases of anaphylaxis, myocardial infarction, pulmonary edema, or seizures occurred. The percentage of reactions was 1.8% for patients who had had previous angiography without ever having had an adverse reaction. In contrast, the percentage of reactions was 48.6% for patients who had had an adverse reaction to angiography previously.
UR - http://www.scopus.com/inward/record.url?scp=0026002905&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026002905&partnerID=8YFLogxK
U2 - 10.1016/S0161-6420(91)32165-1
DO - 10.1016/S0161-6420(91)32165-1
M3 - Article
C2 - 1891225
AN - SCOPUS:0026002905
SN - 0161-6420
VL - 98
SP - 1139
EP - 1142
JO - Ophthalmology
JF - Ophthalmology
IS - 7
ER -